ENTITY
Divi's Laboratories

Divi's Laboratories (DIVI IN)

52
Analysis
Health CareIndia
Divi's Laboratories Ltd. manufactures pharmaceutical products which include generic drugs and their intermediates. The Company also undertakes contract research activities for other pharmaceutical companies.
more
Refresh
bullishHang Seng Index
24 May 2021 09:58

Global Equity Strategy: Value Remains Leadership But Defensives Improving

Cyclical value Sectors continue to be our favorite areas to overweight, while defensive Sectors also continue to be worth a look (i.e., Staples,...

Logo
198 Views
Share
04 Mar 2021 12:19

Divi's Labs: Peak Margins, Peak Valuation and Maturing Growth Profile - Juice Is No More

Divi's is a dominant global API manufacturer but is priced to perfection. With margins and valuations at peak and growth profile maturing, upside...

Logo
256 Views
Share
28 Oct 2020 13:51

Sensex Index Rebalance Preview: Take Profit on Strong Outperformance

With the review period for the Sensex almost complete, we still see DRRD as a high probability inclusion and ONGC as a deletion. With DRRD...

Logo
327 Views
Share
21 Oct 2020 03:04

India:  Confidence Returns Among EM Active Managers

Global EM managers strengthen India exposure during the recent market turbulence.  Ownership increases across Energy and Consumer Discretionary,...

Logo
235 Views
Share
06 Sep 2020 14:25

Sensex Index Rebalance Preview: Early Look Sees One Change, Maybe Two

The S&P BSE Sensex is the flagship index of the Bombay Stock Exchange (BSE). The index has 30 stocks and is a free float weighted market cap...

Logo
667 Views
Share
x